Your browser doesn't support javascript.
loading
Lansoprazole inhibits the cysteine protease legumain by binding to the active site.
Bosnjak, Tatjana; Solberg, Rigmor; Hemati, Paya Diana; Jafari, Abbas; Kassem, Moustapha; Johansen, Harald Thidemann.
Afiliação
  • Bosnjak T; Section for Pharmacology and Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway.
  • Solberg R; Section for Pharmacology and Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway.
  • Hemati PD; Section for Pharmacology and Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway.
  • Jafari A; Department of Cellular and Molecular Medicine, Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark.
  • Kassem M; Department of Cellular and Molecular Medicine, Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark.
  • Johansen HT; Department of Endocrinology and Metabolism, Odense University Hospital & University of Southern Denmark, Odense, Denmark.
Basic Clin Pharmacol Toxicol ; 125(2): 89-99, 2019 Aug.
Article em En | MEDLINE | ID: mdl-30916878
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Cisteína Proteinase / Inibidores da Bomba de Prótons / Lansoprazol Limite: Animals / Humans Idioma: En Revista: Basic Clin Pharmacol Toxicol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Cisteína Proteinase / Inibidores da Bomba de Prótons / Lansoprazol Limite: Animals / Humans Idioma: En Revista: Basic Clin Pharmacol Toxicol Ano de publicação: 2019 Tipo de documento: Article